Standout Papers

Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid 2023 2026 2024110
  1. Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid (2023)
    Pablo García‐Pavía, Fabian aus dem Siepen et al. New England Journal of Medicine

Immediate Impact

7 from Science/Nature 69 standout
Sub-graph 1 of 23

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Cardiac Amyloidosis Due to Transthyretin Protein
2024 Standout
1 intermediate paper

Works of Peter C. Kahr being referenced

Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
2023 Standout
Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury
2016 Nature

Author Peers

Author Last Decade Papers Cites
Peter C. Kahr 348 427 126 137 20 749
Daniel M. DeLaughter 312 602 84 96 17 813
Rachel L. Berry 141 485 124 200 17 868
Elaine E. Wirrig 422 530 205 218 15 889
Rachana Sainger 308 346 99 117 25 909
Polakit Teekakirikul 637 388 92 110 18 898
Anthony Person 236 827 140 157 19 953
Tova Chajek-Shaul 202 278 91 113 22 836
Christina M. Alfieri 480 616 169 182 18 961
Sandra Clark 411 242 91 98 30 894
Aude Dorison 215 435 108 29 13 706

All Works

Loading papers...

Rankless by CCL
2026